Genmab — Marts 2024
-
An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy / Tisotumab - https://aacrjournals.org/mct/article-abstract/23/2/187/733943/An-Antibody-Drug-Conjugate-Directed-to-Tissue?redirectedFrom=fulltext
-
the GEN1046 Endometrial trial ads a few more trial centers , Cohort A closed already, could this be a sign of quick recruitment? https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=7&B=8&C=Side-by-Side#StudyPageTop
-
separate new Epcoritamab trial by the Australasian Leukaemia and Lymphoma Group https://clinicaltrials.gov/study/NCT06287398
-
Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders https://news.cision.com/h--lundbeck-a-s/r/lundbeck-presents-encouraging-results-from-the-lu-af82422-trial-for-multiple-system-atrophy-at-the-i,c3940069
-
Thanks E L .
-
not sure i ever heard of Baader Bank, but it seems they have a buy - Genmab $GMAB 1,954DKK
Baader. Buy. 3,239
️ 3,446DKK https://twitter.com/Quality_stocksA/status/1764913792394129790 -
I meddelelsen fra Genmab angives kurs 27,881, og handelsdato 28. feb.
-
Lundbeck gør klar til fase 3-studie af MSA-middel efter opmuntrende data
Lundbeck bekræfter sine planer om at gå i fase 3 med en kandidat mod multipel system atrofi. https://medwatch.dk/Medicinal___Biotek/article16905404.ece -
Det kunne have noget at gøre med de hygiejneprogrammer, der kører overfor skribenter, der frembringer kritiske indlæg
-
Det er jo ikke alt, der er velkomment her
-
Personangreb, personlige perfiditeter, motivsøgning, spam, ukvemsord og anden facon og sprogbrug som ekskluderer god, venlig og respektfuld debat har nultolerance for her sitet.
-
JV..Hvis du hævder, at jeg censurer skribenter alene på grund at de er kritiske, så kender du selv udgangen.
-
Det var ikke dig, jeg hentydede til Helge - men tak for illustrationen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind